These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 38682801
21. Plasma antimony determination during cutaneous leishmaniasis treatment with intralesional infiltration of meglumine antimoniate. de Aguiar MG, Gonçalves JE, Souza MD, de Silva RE, Silveira JN, Cota G. Trop Med Int Health; 2018 Oct; 23(10):1110-1117. PubMed ID: 30053341 [Abstract] [Full Text] [Related]
22. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis. Salmanpour R, Handjani F, Nouhpisheh MK. J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707 [Abstract] [Full Text] [Related]
23. Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre. Silva RE, Toledo A, Senna MC, Rabello A, Cota G. Mem Inst Oswaldo Cruz; 2016 Aug; 111(8):512-6. PubMed ID: 27508321 [Abstract] [Full Text] [Related]
24. Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis. Rajabi O, Layegh P, Hashemzadeh S, Khoddami M. Dermatol Ther; 2016 Sep; 29(5):358-363. PubMed ID: 27073044 [Abstract] [Full Text] [Related]
25. Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis. Esfandiarpour I, Farajzadeh S, Rahnama Z, Fathabadi EA, Heshmatkhah A. Int J Dermatol; 2012 Oct; 51(10):1221-5. PubMed ID: 22994669 [Abstract] [Full Text] [Related]
26. Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children. Rubiano LC, Miranda MC, Muvdi Arenas S, Montero LM, Rodríguez-Barraquer I, Garcerant D, Prager M, Osorio L, Rojas MX, Pérez M, Nicholls RS, Gore Saravia N. J Infect Dis; 2012 Feb 15; 205(4):684-92. PubMed ID: 22238470 [Abstract] [Full Text] [Related]
27. Fractional Ablative CO2 Laser Followed by Topical Application of Sodium Stibogluconate for Treatment of Active Cutaneous Leishmaniasis: A Randomized Controlled Trial. Artzi O, Sprecher E, Koren A, Mehrabi JN, Katz O, Hilerowich Y. Acta Derm Venereol; 2019 Jan 01; 99(1):53-57. PubMed ID: 30281141 [Abstract] [Full Text] [Related]
28. [Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy]. Yeşilova Y, Turan E, Sürücü HA, Aksoy M, Özbilgin A. Turkiye Parazitol Derg; 2015 Mar 01; 39(1):63-5. PubMed ID: 25917587 [Abstract] [Full Text] [Related]
29. Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. Iraji F, Vali A, Asilian A, Shahtalebi MA, Momeni AZ. Dermatology; 2004 Mar 01; 209(1):46-9. PubMed ID: 15237267 [Abstract] [Full Text] [Related]
31. Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial. Firooz A, Khamesipour A, Ghoorchi MH, Nassiri-Kashani M, Eskandari SE, Khatami A, Hooshmand B, Gorouhi F, Rashighi-Firoozabadi M, Dowlati Y. Arch Dermatol; 2006 Dec 01; 142(12):1575-9. PubMed ID: 17178983 [Abstract] [Full Text] [Related]
34. Effectiveness of meglumine antimoniate against L. tropica in a recently emerged focus of cutaneous leishmaniasis in Birjand, eastern Islamic Republic of Iran. Karamian M, Bojd MS, Salehabadi A, Hemmati M, Barati DA. East Mediterr Health J; 2015 Jun 09; 21(4):280-6. PubMed ID: 26077523 [Abstract] [Full Text] [Related]